To elucidate specific mechanism by which PELI2 inhibits CRC development, we used transcriptome sequencing technology (RNA-Seq) to analyze gene expression between shControl and shPELI2 HCT116 cells. This evidence concerns the gene PELI2 and colorectal carcinoma.